Accredo Pays $45M To Escape Novartis Exjade Kickback Suit
By Margaret Harding McGill · April 30, 2015, 4:21 PM EDT
Specialty pharmacy Accredo Health Group Inc. agreed to pay $45 million to settle allegations it participated in a patient referral kickback scheme with Novartis Pharmaceutical Corp. involving refill prescriptions of an...
To view the full article, register now.